Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients

Conclusions: In summary, the proposed hypoxia-derived signatures are promising biomarkers to predict clinical outcomes and therapeutic responses in stage I LUAD patients.

Source: Theranostics - April 19, 2021 Category: Molecular Biology Authors: Run Shi, Xuanwen Bao, Kristian Unger, Jing Sun, Shun Lu, Farkhad Manapov, Xuanbin Wang, Claus Belka, Minglun Li Tags: Research Paper Source Type: research